Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (BocepreVIH)

This study has been completed.
Rennes University Hospital
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) Identifier:
First received: March 25, 2011
Last updated: October 10, 2014
Last verified: October 2014